Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 365

1.

Ajulemic acid: potential treatment for chronic inflammation.

Burstein SH.

Pharmacol Res Perspect. 2018 Apr;6(2):e00394. doi: 10.1002/prp2.394. Review.

2.

Estrogen receptor beta modulates permeability transition in brain mitochondria.

Burstein SR, Kim HJ, Fels JA, Qian L, Zhang S, Zhou P, Starkov AA, Iadecola C, Manfredi G.

Biochim Biophys Acta. 2018 Jun;1859(6):423-433. doi: 10.1016/j.bbabio.2018.03.006. Epub 2018 Mar 14.

PMID:
29550215
3.

The Oxygen Paradox, the French Paradox, and age-related diseases.

Davies JMS, Cillard J, Friguet B, Cadenas E, Cadet J, Cayce R, Fishmann A, Liao D, Bulteau AL, Derbré F, Rébillard A, Burstein S, Hirsch E, Kloner RA, Jakowec M, Petzinger G, Sauce D, Sennlaub F, Limon I, Ursini F, Maiorino M, Economides C, Pike CJ, Cohen P, Salvayre AN, Halliday MR, Lundquist AJ, Jakowec NA, Mechta-Grigoriou F, Mericskay M, Mariani J, Li Z, Huang D, Grant E, Forman HJ, Finch CE, Sun PY, Pomatto LCD, Agbulut O, Warburton D, Neri C, Rouis M, Cillard P, Capeau J, Rosenbaum J, Davies KJA.

Geroscience. 2017 Dec;39(5-6):499-550. doi: 10.1007/s11357-017-0002-y. Epub 2017 Dec 21. Review.

4.

N-Acyl Amino Acids (Elmiric Acids): Endogenous Signaling Molecules with Therapeutic Potential.

Burstein SH.

Mol Pharmacol. 2018 Mar;93(3):228-238. doi: 10.1124/mol.117.110841. Epub 2017 Nov 14.

PMID:
29138268
5.

In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.

Burstein SR, Valsecchi F, Kawamata H, Bourens M, Zeng R, Zuberi A, Milner TA, Cloonan SM, Lutz C, Barrientos A, Manfredi G.

Hum Mol Genet. 2018 Jan 1;27(1):160-177. doi: 10.1093/hmg/ddx397.

PMID:
29112723
6.

Distinct intracellular sAC-cAMP domains regulate ER Ca2+ signaling and OXPHOS function.

Valsecchi F, Konrad C, D'Aurelio M, Ramos-Espiritu LS, Stepanova A, Burstein SR, Galkin A, Magranè J, Starkov A, Buck J, Levin LR, Manfredi G.

J Cell Sci. 2017 Nov 1;130(21):3713-3727. doi: 10.1242/jcs.206318. Epub 2017 Sep 1.

PMID:
28864766
7.

Sex specific activation of the ERα axis of the mitochondrial UPR (UPRmt) in the G93A-SOD1 mouse model of familial ALS.

Riar AK, Burstein SR, Palomo GM, Arreguin A, Manfredi G, Germain D.

Hum Mol Genet. 2017 Apr 1;26(7):1318-1327. doi: 10.1093/hmg/ddx049.

PMID:
28186560
8.

Cannabinoids, inflammation, and fibrosis.

Zurier RB, Burstein SH.

FASEB J. 2016 Nov;30(11):3682-3689. Epub 2016 Jul 19. Review.

PMID:
27435265
9.

Molecular characterization and antibiotic resistance of group G streptococci in Israel: comparison of invasive, non-invasive and carriage isolates.

Halperin T, Levine H, Korenman Z, Burstein S, Amber R, Sela T, Valinsky L.

Eur J Clin Microbiol Infect Dis. 2016 Oct;35(10):1649-54. doi: 10.1007/s10096-016-2705-x. Epub 2016 Jun 21.

PMID:
27325440
10.

The safety and efficacy of peripheral vascular procedures performed in the outpatient setting.

Mesbah Oskui P, Kloner RA, Burstein S, Zhiroff K, Kartub BR, Economides C, Brook J, Mayeda GS.

J Invasive Cardiol. 2015 May;27(5):243-9.

11.

Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.

Burstein S.

Bioorg Med Chem. 2015 Apr 1;23(7):1377-85. doi: 10.1016/j.bmc.2015.01.059. Epub 2015 Feb 7. Review.

PMID:
25703248
12.

In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist.

Burstein SH, Tepper MA.

Pharmacol Res Perspect. 2013 Dec;1(2):e00017. doi: 10.1002/prp2.17. Epub 2013 Dec 15.

13.

Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity.

Tepper MA, Zurier RB, Burstein SH.

Bioorg Med Chem. 2014 Jul 1;22(13):3245-51. doi: 10.1016/j.bmc.2014.04.062. Epub 2014 May 9.

PMID:
24856183
14.

The cannabinoid acids, analogs and endogenous counterparts.

Burstein SH.

Bioorg Med Chem. 2014 May 15;22(10):2830-43. doi: 10.1016/j.bmc.2014.03.038. Epub 2014 Apr 1. Review.

15.

Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis.

Kawamata H, Ng SK, Diaz N, Burstein S, Morel L, Osgood A, Sider B, Higashimori H, Haydon PG, Manfredi G, Yang Y.

J Neurosci. 2014 Feb 5;34(6):2331-48. doi: 10.1523/JNEUROSCI.2689-13.2014.

16.

Physical therapy for young children diagnosed with autism spectrum disorders-clinical frameworks model in an israeli setting.

Atun-Einy O, Lotan M, Harel Y, Shavit E, Burstein S, Kempner G.

Front Pediatr. 2013 Aug 14;1:19. doi: 10.3389/fped.2013.00019. Review.

17.

Improved myocardial perfusion after transmyocardial laser revascularization in a patient with microvascular coronary artery disease.

Oskui PM, Mayeda GS, Burstein S, Gheissari A, French WJ, Thomas J, Kloner RA.

SAGE Open Med Case Rep. 2014 Mar 4;2:2050313X14526873. doi: 10.1177/2050313X14526873. eCollection 2014.

18.

Testosterone and the cardiovascular system: a comprehensive review of the clinical literature.

Oskui PM, French WJ, Herring MJ, Mayeda GS, Burstein S, Kloner RA.

J Am Heart Assoc. 2013 Nov 15;2(6):e000272. doi: 10.1161/JAHA.113.000272. Review. No abstract available.

19.

Induced synthesis of oestrogens by glia in the songbird brain.

Saldanha CJ, Burstein SR, Duncan KA.

J Neuroendocrinol. 2013 Nov;25(11):1032-8. doi: 10.1111/jne.12067. Review.

PMID:
23795693
20.

Stress differentially alters mu opioid receptor density and trafficking in parvalbumin-containing interneurons in the female and male rat hippocampus.

Milner TA, Burstein SR, Marrone GF, Khalid S, Gonzalez AD, Williams TJ, Schierberl KC, Torres-Reveron A, Gonzales KL, McEwen BS, Waters EM.

Synapse. 2013 Nov;67(11):757-72. doi: 10.1002/syn.21683. Epub 2013 Jul 17.

21.

The influences of reproductive status and acute stress on the levels of phosphorylated delta opioid receptor immunoreactivity in rat hippocampus.

Burstein SR, Williams TJ, Lane DA, Knudsen MG, Pickel VM, McEwen BS, Waters EM, Milner TA.

Brain Res. 2013 Jun 26;1518:71-81. doi: 10.1016/j.brainres.2013.03.051. Epub 2013 Apr 11.

22.

Asymmetric synthesis of novel N-(1-phenyl-2,3-dihydroxypropyl)arachidonylamides and evaluation of their anti-inflammatory activity.

Kattamuri PV, Salmonsen R, McQuain C, Burstein S, Sun H, Li G.

Life Sci. 2013 Mar 19;92(8-9):506-11. doi: 10.1016/j.lfs.2012.06.040. Epub 2012 Jul 20.

23.

Coronary and intracerebral arterial aneurysms in a young adult with acute coronary syndrome.

Yang EH, Kapoor N, Gheissari A, Burstein S.

Tex Heart Inst J. 2012;39(3):380-3.

24.

Emotional stressors trigger cardiovascular events.

Schwartz BG, French WJ, Mayeda GS, Burstein S, Economides C, Bhandari AK, Cannom DS, Kloner RA.

Int J Clin Pract. 2012 Jul;66(7):631-9. doi: 10.1111/j.1742-1241.2012.02920.x. Review.

PMID:
22698415
25.

Treating peripheral arterial disease percutaneously with atherectomy.

Schwartz BG, Kloner RA, Burstein S, Economides C, Mayeda GS.

J Invasive Cardiol. 2012 Jun;24(6):263-9.

26.

Therapeutic hypothermia for acute myocardial infarction and cardiac arrest.

Schwartz BG, Kloner RA, Thomas JL, Bui Q, Mayeda GS, Burstein S, Hale SL, Economides C, French WJ.

Am J Cardiol. 2012 Aug 1;110(3):461-6. doi: 10.1016/j.amjcard.2012.03.048. Epub 2012 Apr 27. Review.

PMID:
22541421
27.

Treating Refractory Cardiogenic Shock With the TandemHeart and Impella Devices: A Single Center Experience.

Schwartz BG, Ludeman DJ, Mayeda GS, Kloner RA, Economides C, Burstein S.

Cardiol Res. 2012 Apr;3(2):54-66. doi: 10.4021/cr121w. Epub 2012 Mar 20.

28.

N-Amino acid linoleoyl conjugates: anti-inflammatory activities.

Burstein S, McQuain C, Salmonsen R, Seicol B.

Bioorg Med Chem Lett. 2012 Jan 15;22(2):872-5. doi: 10.1016/j.bmcl.2011.12.040. Epub 2011 Dec 16.

29.

Impella-assisted balloon aortic valvuloplasty.

Ludeman DJ, Schwartz BG, Burstein S.

J Invasive Cardiol. 2012 Jan;24(1):E19-20.

30.

High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.

Schwartz BG, Ludeman DJ, Mayeda GS, Kloner RA, Economides C, Burstein S.

J Invasive Cardiol. 2011 Oct;23(10):417-24.

31.

Rotational Atherectomy and Stent Implantation for Calcified Left Main Lesions.

Schwartz BG, Mayeda GS, Economides C, Kloner RA, Shavelle DM, Burstein S.

Cardiol Res. 2011 Oct;2(5):208-217. doi: 10.4021/cr78w. Epub 2011 Sep 20.

32.

Resolution of inflammation by N-arachidonoylglycine.

Burstein SH, McQuain CA, Ross AH, Salmonsen RA, Zurier RE.

J Cell Biochem. 2011 Nov;112(11):3227-33. doi: 10.1002/jcb.23245.

33.

Tumor Cell Selective Cytotoxicity and Apoptosis Induction by an Herbal Preparation from Brucea javanica.

Gao H, Lamusta J, Zhang WF, Salmonsen R, Liu Y, O'Connell E, Evans JE, Burstein S, Chen JJ.

N Am J Med Sci (Boston). 2011 Apr 25;4(2):62-66.

34.

Left main stent thrombosis complicated by eptifibatide-induced acute thrombocytopenia.

Yang EH, Perez E, Zhiroff KA, Burstein S.

Tex Heart Inst J. 2011;38(2):174-8.

35.

Rotational atherectomy in the drug-eluting stent era: a single-center experience.

Schwartz BG, Mayeda GS, Economides C, Kloner RA, Shavelle DM, Burstein S.

J Invasive Cardiol. 2011 Apr;23(4):133-9.

PMID:
21474844
36.

Review of vascular closure devices.

Schwartz BG, Burstein S, Economides C, Kloner RA, Shavelle DM, Mayeda GS.

J Invasive Cardiol. 2010 Dec;22(12):599-607. Review.

PMID:
21127366
37.

When and why do heart attacks occur? Cardiovascular triggers and their potential role.

Schwartz BG, Mayeda GS, Burstein S, Economides C, Kloner RA.

Hosp Pract (1995). 2010;38(3):144-52. doi: 10.3810/hp.2010.06.308.

PMID:
20890064
38.

Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock.

Thomas JL, Al-Ameri H, Economides C, Shareghi S, Abad DG, Mayeda G, Burstein S, Shavelle DM.

J Invasive Cardiol. 2010 Aug;22(8):360-4.

39.

The endothelial cell in health and disease: its function, dysfunction, measurement and therapy.

Schwartz BG, Economides C, Mayeda GS, Burstein S, Kloner RA.

Int J Impot Res. 2010 Mar-Apr;22(2):77-90. doi: 10.1038/ijir.2009.59. Epub 2009 Dec 24. Review.

PMID:
20032988
40.

Peripheral chronic total occlusions treated with subintimal angioplasty and a true lumen re-entry device.

Al-Ameri H, Shin V, Mayeda GS, Burstein S, Matthews RV, Kloner RA, Shavelle DM.

J Invasive Cardiol. 2009 Sep;21(9):468-72.

41.

Novel endogenous N-acyl glycines identification and characterization.

Bradshaw HB, Rimmerman N, Hu SS, Burstein S, Walker JM.

Vitam Horm. 2009;81:191-205. doi: 10.1016/S0083-6729(09)81008-X. Review.

PMID:
19647113
42.

Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.

Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M.

JACC Cardiovasc Interv. 2009 Jul;2(7):594-600. doi: 10.1016/j.jcin.2009.05.005.

43.

Identification of endogenous acyl amino acids based on a targeted lipidomics approach.

Tan B, O'Dell DK, Yu YW, Monn MF, Hughes HV, Burstein S, Walker JM.

J Lipid Res. 2010 Jan;51(1):112-9. doi: 10.1194/jlr.M900198-JLR200.

44.

Cannabinoids, endocannabinoids, and related analogs in inflammation.

Burstein SH, Zurier RB.

AAPS J. 2009 Mar;11(1):109-19. doi: 10.1208/s12248-009-9084-5. Epub 2009 Feb 6. Review.

45.

Complication rate of diagnostic carotid angiography performed by interventional cardiologists.

Al-Ameri H, Thomas ML, Yoon A, Mayeda GS, Burstein S, Kloner RA, Shavelle DM.

Catheter Cardiovasc Interv. 2009 Apr 1;73(5):661-5. doi: 10.1002/ccd.21914.

PMID:
19180659
46.

Acylamido analogs of endocannabinoids selectively inhibit cancer cell proliferation.

Burstein S, Salmonsen R.

Bioorg Med Chem. 2008 Nov 15;16(22):9644-51. doi: 10.1016/j.bmc.2008.10.015. Epub 2008 Oct 11.

PMID:
18951802
47.

Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells.

Stebulis JA, Johnson DR, Rossetti RG, Burstein SH, Zurier RB.

Life Sci. 2008 Nov 7;83(19-20):666-70. doi: 10.1016/j.lfs.2008.09.004. Epub 2008 Sep 21.

PMID:
18840450
48.

N-palmitoyl glycine, a novel endogenous lipid that acts as a modulator of calcium influx and nitric oxide production in sensory neurons.

Rimmerman N, Bradshaw HB, Hughes HV, Chen JS, Hu SS, McHugh D, Vefring E, Jahnsen JA, Thompson EL, Masuda K, Cravatt BF, Burstein S, Vasko MR, Prieto AL, O'Dell DK, Walker JM.

Mol Pharmacol. 2008 Jul;74(1):213-24. doi: 10.1124/mol.108.045997. Epub 2008 Apr 18.

49.

The elmiric acids: biologically active anandamide analogs.

Burstein S.

Neuropharmacology. 2008 Dec;55(8):1259-64. doi: 10.1016/j.neuropharm.2007.11.011. Epub 2007 Nov 23. Review.

50.

Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma.

Ambrosio AL, Dias SM, Polikarpov I, Zurier RB, Burstein SH, Garratt RC.

J Biol Chem. 2007 Jun 22;282(25):18625-33. Epub 2007 Apr 26.

Supplemental Content

Loading ...
Support Center